Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection

Annals of Internal Medicine

Volumn 127, Issue 4, 1997, Pages 289-293

  Sahai, Jan ^b   Gallicano, Keith ^a   Swick, Lori ^c   Tailor, Sandra ^d   Garber, Gary ^a   Seguin, Isabelle ^a   Oliveras, Linda ^a   Walker, Scott ^d   Rachlis, Anita ^d   Cameron, D William ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b BioMed Business Unit   (Canada)

^c Sunnybrook Health Sciences Centre ^*  (United States)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 20244364939     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-4-199708150-00006     Document Type: Article

References (20)

1. Peloquin CA, Nitta AT, Burman WJ, Brudney KF, Miranda-Massari JR, McGuinness ME, et al. Low antituberculosis drug concentrations in patients with AIDS. Ann Pharmacother. 1996;30:919-23.
2. Peloquin CA, MacPhee AA, Berning SE. Malabsorption of antimycobacterial medications [Letter]. N Engl J Med. 1993;329:1122-3.
3. Berning SE, Huitt GA, Iseman MD, Peloquin CA. Malabsorption of anti-tuberculosis medications by a patient with AIDS [Letter]. N Engl J Med. 1992; 327:1817-8.
4. Patel KB, Belmonte R, Crowe HM. Drug malabsorption and resistant tuberculosis in HIV-infected patients [Letter]. N Engl J Med. 1995;332:336-7.
5. Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA. 1996;276:1229-35.
6. Bradford WZ, Martin JN, Reingold AL, Schecter GF, Hopewell PC, Small PM. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet. 1996;348:928-31.
7. Drobniewski F. Is death inevitable with multiresistant TB plus HIV infection? Lancet. 1997;349:71-2.
8. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993;329:784-91.
9. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-13.
10. Ehrenpreis ED, Gulino SP, Patterson BK, Craig RM, Yokoo H, Atkinson AJ Jr. Kinetics of D-xylose absorption in patients with human immunodeficiency virus enteropathy. Clin Pharmacol Ther. 1991;49:632-40.
11. Sved S, McGilveray IJ, Beaudoin N. Bioavailability of three isoniazid formulations. J Pharm Sci. 1977;56:1761-4.
12. Gallicano K, Sahai J, Zaror-Behrens G, Pakuts A. Effect of antacids in didanosine tablet on bioavailability of isoniazid. Antimicrob Agents Chemother. 1994;38:894-7.
13. Brouard A, Barreteau H, Merdjan H, Paillet M, Fredj G, Micoud M. Rapid determination of pyrazinamide in biologicai fluids by high-performance liquid chromatography. J Chromatogr. 1985;345:453-6.
14. Swart KJ, Papgis M. Automated high-performance liquid chromatographic method for determination of rifampicin in plasma. J Chromatogr. 1992;593: 21-4.
15. Dowdy S, Wearden S. Statistics for Research 2d ed. New York: J Wiley; 1991.
16. Hutchings A, Routledge PA. A simple method for determining acetylator phenotype using isoniazid. Br J Clin Pharmacol. 1986;22:343-5.
17. Barakat MT, Scott J, Hughes JM, Walport M, Calam J, Friedland JS, et al. Grand rounds - Hassersmith Hospital. Persistent fever in pulmonary tuberculosis (clinical conference) BMJ. 1996;313:1543-5.
18. Lambl BB, Federman M, Pleskow D, Wanke CA. Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea AIDS. 1996;10:739-44.
19. Obinna FC, Cook G, Beale T, Dave S, Cunningham D, Fleming SC, et al. Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men. AIDS. 1995;9:1009-16.
20. Alford RH, Wallace RJ. Antimycobacterial agents. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone; 1995:389-400.